biote Corp.
BTMD
$3.47
$0.041.17%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 197.19M | 193.06M | 187.23M | 187.32M | 185.36M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 197.19M | 193.06M | 187.23M | 187.32M | 185.36M |
| Cost of Revenue | 58.13M | 57.83M | 56.83M | 57.37M | 57.88M |
| Gross Profit | 139.06M | 135.23M | 130.41M | 129.95M | 127.48M |
| SG&A Expenses | 101.38M | 95.44M | 92.39M | 89.47M | 89.54M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 159.51M | 153.27M | 149.22M | 146.84M | 147.42M |
| Operating Income | 37.68M | 39.79M | 38.02M | 40.49M | 37.94M |
| Income Before Tax | 1.02M | 11.57M | 19.23M | 17.35M | -123.00K |
| Income Tax Expenses | 970.00K | 2.93M | 3.61M | 4.54M | 2.68M |
| Earnings from Continuing Operations | 0.05 | 8.64 | 15.63 | 12.82 | -2.81 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 3.11M | -1.45M | -11.61M | -4.76M | 6.12M |
| Net Income | 3.16M | 7.19M | 4.02M | 8.05M | 3.32M |
| EBIT | 37.68M | 39.79M | 38.02M | 40.49M | 37.94M |
| EBITDA | 39.19M | 40.97M | 39.17M | 41.39M | 38.73M |
| EPS Basic | 0.13 | 0.24 | 0.14 | 0.17 | -0.16 |
| Normalized Basic EPS | 0.64 | 0.55 | 0.23 | 0.38 | 1.11 |
| EPS Diluted | 0.09 | 0.11 | 0.02 | 0.05 | -0.28 |
| Normalized Diluted EPS | 0.63 | 0.55 | 0.23 | 0.39 | 1.12 |
| Average Basic Shares Outstanding | 130.02M | 132.72M | 132.01M | 119.64M | 102.61M |
| Average Diluted Shares Outstanding | 137.24M | 163.31M | 162.09M | 149.72M | 132.68M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 147.48% | 80.16% | 157.10% | 70.60% | 262.18% |